83 FR 43693 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 166 (August 27, 2018)

Page Range		43693-43693
FR Document		2018-18399
Federal Register, Volume 83 Issue 166 (Monday, August 27, 2018)
[Federal Register Volume 83, Number 166 (Monday, August 27, 2018)]
[Notices]
[Page 43693]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18399]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE III.
    Date: September 19-20, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Scientific 
Review Officer, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W514, Bethesda, MD 20892-9750, 240-276-6340, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP 4 for Provocative Questions.
    Date: September 21, 2018.
    Time: 7:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1 for Provocative Questions.
    Date: October 4, 2018.
    Time: 7:30 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville, 
MD 20850.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-3 for Provocative Questions.
    Date: October 9, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Traceback Testing: Identification and Genetic Counseling of 
Mutation Carriers (U01).
    Date: October 10, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5007, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5 for Provocative Questions.
    Date: October 18-19, 2018.
    Time: 6:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1 NCI Clinical and Translational R21 and Omnibus R03.
    Date: October 25, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI U01 Review: Integrating Biospecimens into Clinical Assay 
Development.
    Date: November 15, 2018.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W116, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W116, Bethesda, MD 20892-9750, 240-276-7849, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: August 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-18399 Filed 8-24-18; 8:45 am]
BILLING CODE 4140-01-P
Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43693

address/telephone number listed above Name of Committee: National Cancer Place: Bethesda Marriott Suites, 6711
at least one week prior to the meeting. Institute Special Emphasis Panel; SEP 4 for Democracy Boulevard, Bethesda, MD 20817.
For those unable to attend in person, a Provocative Questions. Contact Person: Byeong-Chel Lee, Ph.D.,
Date: September 21, 2018. Scientific Review Officer, Resources and
live webcast will be available. More Time: 7:30 a.m. to 6:00 p.m.
information on registration and Training Review Branch, Division of
Agenda: To review and evaluate grant
accessing the webcast can be found at applications. Extramural Activities, National Cancer
http://www.hhs.gov/ash/carb/. Place: Bethesda North Marriott Hotel & Institute, NIH, 9609 Medical Center Drive,
Members of the public will have the Conference Center, 5701 Marinelli Road, Room 7W238, Bethesda, MD 20892–9750,
opportunity to provide comments prior North Bethesda, MD 20852. 240–276–7755, byeong-chel.lee@nih.gov.
to the Advisory Council meeting by Contact Person: Clifford W. Schweinfest, Name of Committee: National Cancer
emailing CARB@hhs.gov. Public Ph.D., Scientific Review Officer, Special Institute Special Emphasis Panel; SEP–1 NCI
comments should be sent in by Review Branch, Division of Extramural
Clinical and Translational R21 and Omnibus
Activities, National Cancer Institute, NIH,
midnight September 19, 2018, and 9609 Medical Center Drive, Room 7W108, R03.
should be limited to no more than one Bethesda, MD 20892–9750, 240–276–6343, Date: October 25, 2018.
page. All public comments received schweinfestcw@mail.nih.gov. Time: 10:00 a.m. to 5:00 p.m.
prior to September 19, 2018, will be Name of Committee: National Cancer Agenda: To review and evaluate grant
provided to Advisory Council members; Institute Special Emphasis Panel; SEP–1 for applications.
comments are limited to two minutes Provocative Questions. Place: National Cancer Institute, Shady
per speaker. Date: October 4, 2018. Grove, 9609 Medical Center Drive, Room
Time: 7:30 a.m. to 4:00 p.m. 7W242, Rockville, MD 20850 (Telephone
Dated: August 21, 2018.
Agenda: To review and evaluate grant Conference Call).
Jomana F. Musmar, applications. Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Acting Designated Federal Officer, Place: Cambria Hotel Rockville, 1 Helen
Scientific Review Officer, Special Review
Presidential Advisory Council on Combating Heneghan Way, Rockville, MD 20850.
Antibiotic-Resistant Bacteria Committee Contact Person: Hasan Siddiqui, Ph.D., Branch, Division of Extramural Activities,
Manager. Scientific Review Officer, Special Review National Cancer Institute, NIH, 9609 Medical
[FR Doc. 2018–18483 Filed 8–24–18; 8:45 am] Branch, Division of Extramural Activities, Center Drive, Room 7W242, Bethesda, MD
National Cancer Institute, NIH, 9609 Medical 20892–9750, 240–276–6372, zouzhiq@
BILLING CODE 4150–44–P
Center Drive, Room 7W240, Bethesda, MD mail.nih.gov.
20892–9750, 240–276–5122, hasan.siddiqui@ Name of Committee: National Cancer
nih.gov. Institute Special Emphasis Panel; NCI U01
DEPARTMENT OF HEALTH AND
Name of Committee: National Cancer Review: Integrating Biospecimens into
HUMAN SERVICES
Institute Special Emphasis Panel; SEP–3 for Clinical Assay Development.
Provocative Questions.
National Institutes of Health Date: November 15, 2018.
Date: October 9, 2018.
Time: 8:00 a.m. to 6:00 p.m. Time: 12:00 p.m. to 2:00 p.m.
National Cancer Institute; Notice of Agenda: To review and evaluate grant
Agenda: To review and evaluate grant
Closed Meetings applications. applications.
Pursuant to section 10(d) of the Place: Bethesda North Marriott Hotel & Place: National Cancer Institute, Shady
Federal Advisory Committee Act, as Conference Center, 5701 Marinelli Road, Grove, 9609 Medical Center Drive, Room
North Bethesda, MD 20852. 7W116, Rockville, MD 20850 (Telephone
amended, notice is hereby given of the Contact Person: Adriana Stoica, Ph.D.,
following meetings. Conference Call).
Scientific Review Officer, Resources and Contact Person: Klaus B. Piontek, Ph.D.,
The meetings will be closed to the Training Review Branch, Division of
public in accordance with the Scientific Review Officer, Research Programs
Extramural Activities, National Cancer
provisions set forth in sections Review Branch, Division of Extramural
Institute, NIH, 9609 Medical Center Drive,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Room 7W234, Bethesda, MD 20892–9750, Activities, National Cancer Institute, NIH,
240–276–6368, Stoicaa2@mail.nih.gov. 9609 Medical Center Drive, Room 7W116,
as amended. The grant applications and
Name of Committee: National Cancer Bethesda, MD 20892–9750, 240–276–7849,
the discussions could disclose
Institute Special Emphasis Panel; Traceback klaus.piontek@nih.gov.
confidential trade secrets or commercial
property such as patentable material, Testing: Identification and Genetic (Catalogue of Federal Domestic Assistance
Counseling of Mutation Carriers (U01). Program Nos. 93.392, Cancer Construction;
and personal information concerning
Date: October 10, 2018. 93.393, Cancer Cause and Prevention
individuals associated with grant Time: 11:00 a.m. to 1:00 p.m.
applications, the disclosure of which Research; 93.394, Cancer Detection and
Agenda: To review and evaluate grant Diagnosis Research; 93.395, Cancer
would constitute a clearly unwarranted applications.
invasion of personal privacy. Treatment Research; 93.396, Cancer Biology
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room Research; 93.397, Cancer Centers Support;
Name of Committee: National Cancer 93.398, Cancer Research Manpower; 93.399,
Institute Special Emphasis Panel; NCI SPORE 7W248, Rockville, MD 20850 (Telephone
Conference Call). Cancer Control, National Institutes of Health,
III.
Date: September 19–20, 2018. Contact Person: Anita T. Tandle, Ph.D., HHS)
Time: 5:00 p.m. to 5:00 p.m. Scientific Review Officer, Research Programs
Agenda: To review and evaluate grant Review Branch, Division of Extramural Dated: August 20, 2018.
applications. Activities, National Cancer Institute, NIH, Melanie J. Pantoja,
Place: Gaithersburg Marriott 9609 Medical Center Drive, Room 7W248,
Bethesda, MD 20892–9750, 240–276–5007, Program Analyst, Office of Federal Advisory
Washingtonian Center, 9751 Washingtonian Committee Policy.
amozie on DSK3GDR082PROD with NOTICES1

Boulevard, Gaithersburg, MD 20878. tandlea@mail.nih.gov.
Name of Committee: National Cancer [FR Doc. 2018–18399 Filed 8–24–18; 8:45 am]
Contact Person: Wlodek Lopaczynski,
M.D., Ph.D., Scientific Review Officer, Institute Special Emphasis Panel; SEP–5 for BILLING CODE 4140–01–P
Research Programs Review Branch, Division Provocative Questions.
of Extramural Activities, National Cancer Date: October 18–19, 2018.
Institute, NIH, 9609 Medical Center Drive, Time: 6:00 p.m. to 5:00 p.m.
Room 7W514, Bethesda, MD 20892–9750, Agenda: To review and evaluate grant
240–276–6340, lopacw@mail.nih.gov. applications.

VerDate Sep<11>2014 17:51 Aug 24, 2018 Jkt 244001 PO 00000 Frm 00060 Fmt 4703 Sfmt 9990 E:\FR\FM\27AUN1.SGM 27AUN1
Document Created: 2018-08-25 01:48:29
Document Modified: 2018-08-25 01:48:29
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 19-20, 2018.
FR Citation		83 FR 43693